Registration - In-house Corporation

Amgen Canada Inc. / Ugur Gunaydin, General Manager, Canada

Registration Information

In-house Corporation name: Amgen Canada Inc.
Responsible Officer Name: Ugur Gunaydin, General Manager, Canada
Responsible Officer Change History
Initial registration start date: 2007-05-16
Registration status: Active
Registration Number: 952471-15332

Associated Communications

Total Number of Communication Reports: 138

Monthly communication reports in the last 6 months: 9

Version 6 of 31 (2009-12-01 to 2011-03-14)

Registration versions:

Version 6 of 31 (2009-12-01 to 2011-03-14)

Lobbying Information

Subject Matters

Cross-border Trade
Federally-Funded Health Benefits Programs
Health
Industry
Intellectual Property
International Trade
Pharmaceutical Policies and Regulations
Science and Technology
Sports
Taxation and Finance

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Food and Drugs Act Modernization initiative, as it relates to reform of drug submission review and approval process.

Legislative Proposal, Bill or Resolution, Regulation

Food and Drugs Act and Regulations, as they relate to drug export and cross-border trade.
Food and Drugs Act and Regulations, as they relate to the establishment of an approval framework for subsequent entry biologic products.
Food and Drugs Act and Regulations, as they relate to the provision of data exclusivity for innovative drug products.
Food and Drugs Act and Regulations, as they relate to the review and approval of new drug submissions and post market surveillance of drug products.
Patent Act and Patented Medicines (Notice of Compliance) Regulations, as it relates to the regulation of intellectual property and approval for therapeutic products.
Patented Medicine Prices Review Board (PMPRB), as it relates to reporting requirements, pricing guidelines, and dispute resolution.

Policies or Program

Common Drug Review, as it relates to health technology assessments and drug product reimbursement recommendations.
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Industry Canada Advantage Canada and Science and Technology Strategies, or other Government policy or program initiatives to support research and development activities in Canada.
National Pharmaceutical Strategy, as it relates to enhanced access to orphan drugs and incentives for development of the treatments for rare disorders.

Communication Techniques

Written communication
Oral communication
As part of industry associations including IMC and BIOTECanada

Government Institutions

Canadian Heritage (PCH)
Canadian Institutes of Health Research (CIHR)
Canadian International Development Agency (CIDA)
Democratic Reform
Finance Canada (FIN)
Foreign Affairs and International Trade Canada (DFAITC)
Health Canada (HC)
House of Commons
Immigration and Refugee Board (IRB)
Industry Canada
Patented Medicine Prices Review Board (PMPRB)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Transport, Infrastructure and Communities

In-house Corporation Details

Description of activities

Scientific affairs, commercial operations and administrative activities in biotechnology and pharmaceutical sector.

Responsible officer name and position during the period of this registration

Daniel Billen, Vice President & General Manager

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
6755 Mississauga Road
Mississauga, ON L5N 7Y2
Canada

Telephone number: 416-643-6817

Parent Company Information

Amgen Inc.
- One Amgen Center Drive
  Thousand Oaks, CA 91320-1799
  United States of America

Subsidiary Beneficiary Information

Amgen Canada Inc. does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Daniel Billen, Vice President & General Manager | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Kim Furlong, Director, Federal Government Affairs | Public offices held

Amgen Canada Inc.

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Amgen Canada Inc.	2008-07-02	current

The following names have been used before July 2, 2008

Amgen Canada Inc.

Amgen Canada Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)
Ugur Gunaydin	2022-06-06	Current
Roman Stampfli	2022-01-17	2022-06-06
Brian Heath	2019-10-14	2022-01-17
Francesco Di Marco	2017-10-26	2019-10-14
Helen Jordan	2014-05-02	2017-10-26
Anand Varadan	2011-09-13	2014-05-02
Daniel Billen	2007-05-16	2011-09-13

Ugur Gunaydin, General Manager, Canada (Corporation)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-138 of 138

Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ophelia John, Senior Policy Advisor | Office of the Minister | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2024-03-05
Posted date: 2024-04-15
Communication number: 15332-600597 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yasir Naqvi, Parliamentary Secretary to the Minister of Health | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597313 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francesco Sorbara, Member of Parliament for Vaughan—Woodbridge | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597310 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Luc Thériault, Member of Parliament for Montcalm | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597306 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Robert Black, Senator for Ontario | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597303 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rachel Blaney, Member of Parliament for North Island—Powell River | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597299 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dan Albas, Member of Parliament for Central Okanagan—Similkameen—Nicola | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597297 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Earl Dreeshen, Member of Parliament for Red Deer—Mountain View | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597293 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tom Kmiec, Member of Parliament for Calgary Shepard | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597290 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Ellis, Member of Parliament for Cumberland—Colchester | House of Commons
Subject Matter of the communication: Health
Communication date: 2023-09-13
Posted date: 2023-10-06
Communication number: 15332-577801 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Stephen Ellis, Member of Parliament for Cumberland—Colchester | House of Commons
Subject Matter of the communication: Health, Science and Technology, Research and Development
Communication date: 2023-08-03
Posted date: 2023-08-15
Communication number: 15332-574844 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ritu Banerjee, Assistant Deputy Minister | Office of Life Sciences and Biomanufacturing Readiness | Innovation, Science and Economic Development Canada (ISED)
- Andy Fillmore, Parliamentary Secretary to the Minister of Innovation, Science and Industry | House of Commons
Subject Matter of the communication: Health, Science and Technology
Communication date: 2023-06-05
Posted date: 2023-06-15
Communication number: 15332-569870 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jocelyne Voisin, Assistant Deputy Minister, Strategic Policy Branch | Health Canada (HC)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2023-04-24
Posted date: 2023-05-13
Communication number: 15332-565320 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hilary Peirce, Senior Policy Advisor | Office of the President | Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2022-11-30
Posted date: 2022-12-15
Communication number: 15332-551822 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Camille Benoit-Blouin, Special Assistant to the Chief of Staff and Regional Affairs (Québec) | Office of the Minister of International Trade | Global Affairs Canada (GAC)
- Zachary Nixon, Senior Advisor | Office of the Minister of International Trade | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-23
Posted date: 2022-12-15
Communication number: 15332-551795 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ashley Wright, Chief of Staff | Office of the Minister of International Development | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-23
Posted date: 2022-12-15
Communication number: 15332-551793 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jessie Pierre, Director of Policy | Office of the Minister | Federal Economic Development Agency for Southern Ontario (FedDev)
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-23
Posted date: 2022-12-15
Communication number: 15332-551789 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Peter Fragiskatos, Member of Parliament for London North Centre | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-15
Posted date: 2022-12-15
Communication number: 15332-551805 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- François-Philippe Champagne, Minister of Innovation, Sciences and Economic Development | House of Commons
Subject Matter of the communication: Health, Industry
Communication date: 2022-11-15
Posted date: 2022-12-15
Communication number: 15332-551801 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Yves Duclos, Minister | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-12-02
Posted date: 2022-01-15
Communication number: 15332-518357 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean-Sébastien Bock, Director of Policy | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-11-26
Posted date: 2021-12-16
Communication number: 15332-518360 (amended from 15332-518359) View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Sabourin, Assistant Deputy Minister | Health Products and Food Branch | Health Canada (HC)
- Stefania Trombetti, Assistant Deputy Minister | Regulatory Operations and Enforcement | Health Canada (HC)
- Marcel Saulnier, Assistant Deputy Minister | Health Care Strategies Directorate | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2021-06-15
Posted date: 2021-07-15
Communication number: 15332-511282 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- François-Philippe Champagne, Minister of Innovation, Science and Industry | Innovation, Science and Economic Development Canada (ISED)
- Amanda Woodley, Policy Advisor | Office of the Minister, Minister's Office | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Industry, Intellectual Property, International Trade
Communication date: 2021-04-29
Posted date: 2021-05-14
Communication number: 15332-504732 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Marcel Saulnier, Assistant Deputy Minister | Health Care Strategies Directorate | Health Canada (HC)
- Michelle Kovacevic, Assistant Deputy Minister | Federal-Provincial Relations and Social Policy Branch | Finance Canada (FIN)
Subject Matter of the communication: Health, Research and Development
Communication date: 2020-02-20
Posted date: 2020-03-16
Communication number: 15332-468243 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jason Easton, Chief of Staff | Exempt Staff | Global Affairs Canada (GAC)
- Ivana Spasovska, Senior Special Assistant | Regional Affairs (ON) and Stakeholder Relations | Global Affairs Canada (GAC)
- Arthur Lam, Senior Policy Advisor | Exempt Staff | Global Affairs Canada (GAC)
Subject Matter of the communication: Health, Research and Development
Communication date: 2020-02-20
Posted date: 2020-03-16
Communication number: 15332-468240 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ryan Dunn, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
- Celine Caira, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Research and Development
Communication date: 2020-02-20
Posted date: 2020-03-16
Communication number: 15332-468238 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gagan Sikand, Member of Parliament | Mississauga - Streetsville | House of Commons
Subject Matter of the communication: Health, Research and Development
Communication date: 2020-02-13
Posted date: 2020-03-16
Communication number: 15332-468235 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Iqra Khalid, Member of Parliament | Mississauga-Erin Mill | House of Commons
- Peter Fonseca, Member of Parliament | Mississauga East – Cooksville | House of Commons
Subject Matter of the communication: Health, Intellectual Property, Research and Development
Communication date: 2020-01-13
Posted date: 2020-02-15
Communication number: 15332-465033 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gianluca Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2018-10-12
Posted date: 2018-11-06
Communication number: 15332-437066 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hilary Travis, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2018-07-12
Posted date: 2018-08-10
Communication number: 15332-432057 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Director of Policy | Health Canada (HC)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2018-07-11
Posted date: 2018-08-10
Communication number: 15332-432056 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Director of Policy | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2018-02-14
Posted date: 2018-03-13
Communication number: 15332-421609 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Justin Trudeau, Prime Minister | Prime Minister's Office (PMO)
Subject Matter of the communication: Health
Communication date: 2018-02-08
Posted date: 2018-03-13
Communication number: 15332-421608 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gianluca Cairo, Chief of Staff | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health
Communication date: 2018-02-05
Posted date: 2018-03-13
Communication number: 15332-421607 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sven Spengemann, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-12-18
Posted date: 2018-01-15
Communication number: 15332-418295 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francesco Sorbara, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-12-07
Posted date: 2018-01-15
Communication number: 15332-418294 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Oliphant Robert, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-11-15
Posted date: 2017-12-07
Communication number: 15332-414871 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
- Travis Hilary, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-11-14
Posted date: 2017-12-07
Communication number: 15332-414870 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gagan Sikand, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-11-09
Posted date: 2017-12-07
Communication number: 15332-414869 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-11-06
Posted date: 2017-12-07
Communication number: 15332-414868 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Caroline Pitfield, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-11-06
Posted date: 2017-12-07
Communication number: 15332-414867 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maxime Dea, Policy Advisor | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-10-30
Posted date: 2017-11-15
Communication number: 15332-413001 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kathryn Nowers, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-10-30
Posted date: 2017-11-15
Communication number: 15332-413000 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul McCarthy, Director of Policy | Veterans Affairs Canada (VAC)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-09-27
Posted date: 2017-10-16
Communication number: 15332-410288 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maxime Bernier, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-09-26
Posted date: 2017-10-16
Communication number: 15332-410286 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gagan Sikand, Member of Parliament | House of Commons
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-09-15
Posted date: 2017-10-16
Communication number: 15332-410285 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Beauchemin, Advisor, Canada-US Relations | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-09-14
Posted date: 2017-10-16
Communication number: 15332-410284 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Hilary Travis, Special Assistant (Policy) | Innovation, Science and Economic Development Canada (ISED)
- David McFarlane, Director of Policy | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-09-13
Posted date: 2017-10-16
Communication number: 15332-410283 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Javid Dharas, Policy Advisor | Innovation, Science and Economic Development Canada (ISED)
Subject Matter of the communication: Intellectual Property
Communication date: 2017-09-07
Posted date: 2017-10-16
Communication number: 15332-410282 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tisha Ashton, Director of Policy | Treasury Board Of Canada Secretariat (TBS)
Subject Matter of the communication: Intellectual Property
Communication date: 2017-08-23
Posted date: 2017-09-08
Communication number: 15332-407419 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Robert Asselin, Policy & Budget Director | Finance Canada (FIN)
Subject Matter of the communication: Health
Communication date: 2017-06-14
Posted date: 2017-07-16
Communication number: 15332-405825 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kevin Ogilvie, Senator | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2017-06-14
Posted date: 2017-07-16
Communication number: 15332-405824 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Caroline Pitfield, Director of Policy | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2017-06-07
Posted date: 2017-07-16
Communication number: 15332-405823 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Director General | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2017-02-13
Posted date: 2017-03-15
Communication number: 15332-396421 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dennis Dawson, Senator | Senate of Canada
Subject Matter of the communication: International Trade
Communication date: 2017-02-08
Posted date: 2017-03-15
Communication number: 15332-396420 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ashleigh White, Special Assistant-Western Desk | Health Canada (HC)
- Mark Livingstone, Special Assistant-Atlantic Regional Desk | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2016-11-03
Posted date: 2016-12-15
Communication number: 15332-387618 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ashleigh White, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2016-09-28
Posted date: 2016-10-13
Communication number: 15332-385100 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jesse Kancir, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2016-08-19
Posted date: 2016-09-15
Communication number: 15332-382843 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2016-05-02
Posted date: 2016-06-16
Communication number: 15332-380125 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Simon Kennedy, Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2016-04-14
Posted date: 2016-05-12
Communication number: 15332-376353 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Douglas Clark, Executive Director | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2016-04-01
Posted date: 2016-05-12
Communication number: 15332-376352 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maxime Bernier, Member of Parliament | House of Commons
Subject Matter of the communication: Industry
Communication date: 2016-02-26
Posted date: 2016-03-15
Communication number: 15332-372368 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Paul Glover, Associate Deputy Minister | Health Canada (HC)
- Simon Kennedy, Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Health, Science and Technology
Communication date: 2015-09-16
Posted date: 2015-10-15
Communication number: 15332-362043 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Elena Lungu, Senior Economic Analyst | POLICY AND ECONOMIC ANALYSIS BRANCH | Patented Medicine Prices Review Board (PMPRB)
- Jeffrey Biggs, Manager, Policy Development | POLICY AND ECONOMIC ANALYSIS BRANCH | Patented Medicine Prices Review Board (PMPRB)
- Branka Pejcic-Karapetrovic, Pharmaceutical Analyst/Research | POLICY AND ECONOMIC ANALYSIS BRANCH | Patented Medicine Prices Review Board (PMPRB)
Subject Matter of the communication: Health, Industry, Intellectual Property
Communication date: 2015-07-29
Posted date: 2015-08-15
Communication number: 15332-359911 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jean Pruneau, Executive Director | OFFICE OF PHARMACEUTICALS MANAGEMENT STRATEGIES | Health Canada (HC)
- Frances Hall, Director | OFFICE OF PHARMACEUTICALS MANAGEMENT STRATEGIES | Health Canada (HC)
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology
Communication date: 2015-07-29
Posted date: 2015-08-15
Communication number: 15332-359910 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gerard Peets, Director General | Manufacturing and Life Sciences Branch | Industry Canada
- Neil MacIntosh, Manager | Manufacturing and Life Sciences Branch | Industry Canada
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2015-07-29
Posted date: 2015-08-15
Communication number: 15332-359909 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kelvin Kenneth Ogilvie, Senator | Senate of Canada
Subject Matter of the communication: Health, Industry
Communication date: 2014-09-16
Posted date: 2014-10-15
Communication number: 15332-336015 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Pierre Claude Nolin, Senator | Senate of Canada
Subject Matter of the communication: Health, Industry
Communication date: 2014-09-15
Posted date: 2014-10-15
Communication number: 15332-336012 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- The Honourable Maxime Bernier, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2014-05-07
Posted date: 2014-06-15
Communication number: 15332-327761 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Colin Carrie, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2014-05-07
Posted date: 2014-06-15
Communication number: 15332-327760 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rod Bruinooge, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2014-05-06
Posted date: 2014-06-15
Communication number: 15332-327759 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Randy Hoback, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2014-05-06
Posted date: 2014-06-15
Communication number: 15332-327757 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- James Rajotte, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2014-05-06
Posted date: 2014-06-15
Communication number: 15332-327756 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kirsty Duncan, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2014-05-06
Posted date: 2014-06-15
Communication number: 15332-327755 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Alayna Johnson, Policy Advisor | MINISTER OF INDUSTRY | Industry Canada
Subject Matter of the communication: Health, Industry, Science and Technology
Communication date: 2013-10-01
Posted date: 2013-11-13
Communication number: 15332-302992 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean O'Leary, Director of Policy | MINISTER OF STATE, SCIENCE AND TECHNOLOGY, AND FEDNOR | Industry Canada
- Gary Toft, Chief of Staff | MINISTER OF STATE, SCIENCE AND TECHNOLOGY, AND FEDNOR | Industry Canada
Subject Matter of the communication: Science and Technology
Communication date: 2013-09-13
Posted date: 2013-10-15
Communication number: 15332-297020 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Schaan, Director | Life Science Branch | Industry Canada
Subject Matter of the communication: Industry
Communication date: 2013-07-30
Posted date: 2013-08-16
Communication number: 15332-287189 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jeannie Smith, Chief of Staff | Federal Economic Development Agency for Southern Ontario (FedDev)
Subject Matter of the communication: Science and Technology
Communication date: 2013-05-29
Posted date: 2013-06-17
Communication number: 15332-277776 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maxime Bernier, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2013-05-01
Posted date: 2013-06-17
Communication number: 15332-277773 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leah Canning, Director of Policy | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Health, Intellectual Property
Communication date: 2013-01-24
Posted date: 2013-02-15
Communication number: 15332-258049 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Mark Adler, Members of the House of Commons | House of Commons
- Colin Carrie, Members of the House of Commons | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2012-10-18
Posted date: 2012-11-15
Communication number: 15332-244312 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andrew Rankin, Policy Advisor | Finance Canada (FIN)
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2012-10-17
Posted date: 2012-11-15
Communication number: 15332-244311 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rick Dykstra, Members of the House of Commons | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2012-10-16
Posted date: 2012-11-09
Communication number: 15332-244310 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Randy Hoback, Members of the House of Commons | House of Commons
- Kelvin Ogilvie, Honourable Senator | Senate of Canada
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2012-10-15
Posted date: 2012-11-15
Communication number: 15332-244309 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maxime Bernier, Minister of State | Industry Canada
- Kelvin Ogilvie, HONOURABLE SENATORS | Senate of Canada
- Rick Dykstra, Member of Parliament | House of Commons
- Merv Tweed, Member of Parliament | House of Commons
- Andrew Saxton, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2012-06-06
Posted date: 2012-07-15
Communication number: 15332-229970 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Alykhan Velshi, Director of Planning | Prime Minister's Office (PMO)
Subject Matter of the communication: Health, International Trade
Communication date: 2012-06-04
Posted date: 2012-07-15
Communication number: 15332-229969 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kirsty Duncan, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2012-04-25
Posted date: 2012-05-15
Communication number: 15332-222709 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rob Merrifield, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2012-04-25
Posted date: 2012-05-15
Communication number: 15332-222708 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maxime Bernier, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2012-04-25
Posted date: 2012-05-15
Communication number: 15332-222707 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kirsty Duncan, Member of Parliament | House of Commons
Subject Matter of the communication: Industry
Communication date: 2012-03-26
Posted date: 2012-04-16
Communication number: 15332-215835 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Toone, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2012-03-07
Posted date: 2012-04-16
Communication number: 15332-215834 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Carmichael, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2012-03-05
Posted date: 2012-04-16
Communication number: 15332-215833 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Brian Jean, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2012-02-17
Posted date: 2012-03-16
Communication number: 15332-211168 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Chris Warkentin, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2012-02-13
Posted date: 2012-03-16
Communication number: 15332-211167 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Maxime Bernier, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2011-12-07
Posted date: 2012-01-16
Communication number: 15332-202027 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Shelly Glover, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2011-11-23
Posted date: 2011-12-16
Communication number: 15332-197429 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Kelvin Ogilvie, Senator | Senate of Canada
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2011-11-22
Posted date: 2011-12-16
Communication number: 15332-197409 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- John Williamson, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2011-11-17
Posted date: 2011-12-16
Communication number: 15332-197408 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Andrea McGuigan, Policy Advisor | Foreign Affairs, Environment & Energy Security | Prime Minister's Office (PMO)
Subject Matter of the communication: Intellectual Property, International Trade
Communication date: 2011-11-16
Posted date: 2011-12-16
Communication number: 15332-197407 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Eve Adams, Member of Parliament | House of Commons
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2011-10-27
Posted date: 2011-11-16
Communication number: 15332-193112 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gerald Keddy, Member of Parliament | House of Commons
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2011-10-18
Posted date: 2011-11-16
Communication number: 15332-193111 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Colin Carrie, Member of Parlaiment | House of Commons
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2011-10-18
Posted date: 2011-11-16
Communication number: 15332-193110 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Philip Jennings, Associate Assistant Deputy Minister | Industry Sector | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2011-10-14
Posted date: 2011-12-07
Communication number: 15332-193099 (amended from 15332-193098) View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean O'Leary, Policy Advisor | Minister of Industry | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2011-10-12
Posted date: 2011-12-07
Communication number: 15332-193101 (amended from 15332-193097) View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Scott Tessier, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2011-10-11
Posted date: 2011-12-07
Communication number: 15332-193106 (amended from 15332-193096) View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rick Dykstra, Member of Parliament | House of Commons
Subject Matter of the communication: Industry, Intellectual Property
Communication date: 2011-10-04
Posted date: 2011-12-07
Communication number: 15332-193109 (amended from 15332-193095) View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Louise Girouard, Director of Policy and Stakeholder Relations | Office of the Minister for International Trade | Foreign Affairs and International Trade Canada (DFAITC)
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2011-10-04
Posted date: 2011-12-07
Communication number: 15332-193108 (amended from 15332-193089) View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Wayne Easter, Member of Parliament | House of Commons
Subject Matter of the communication: Industry, Intellectual Property, International Trade
Communication date: 2011-10-04
Posted date: 2011-12-07
Communication number: 15332-193107 (amended from 15332-193093) View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Richard Dicerni, Deputy Minister | Industry Canada
Subject Matter of the communication: Industry, Taxation and Finance
Communication date: 2011-09-20
Posted date: 2011-10-16
Communication number: 15332-188831 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Graham Howell, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2011-09-20
Posted date: 2011-10-16
Communication number: 15332-188830 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Carlo Oliviero, Special Assistant and Stakeholder and Caucus Liaison | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2011-09-20
Posted date: 2011-10-16
Communication number: 15332-188829 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dany Morin, Member of Parliament | House of Commons
Subject Matter of the communication: Industry, Science and Technology
Communication date: 2011-09-20
Posted date: 2011-10-16
Communication number: 15332-188828 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean O'Leary, Policy Advisor | Industry Canada
Subject Matter of the communication: Industry, Intellectual Property
Communication date: 2011-06-23
Posted date: 2011-07-20
Communication number: 15332-175807 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rick Dykstra, Member of Parliament | House of Commons
Subject Matter of the communication: Industry, Intellectual Property
Communication date: 2011-06-22
Posted date: 2011-07-20
Communication number: 15332-175805 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Keith Martin, Member of Parliament | House of Commons
Subject Matter of the communication: Intellectual Property
Communication date: 2010-11-15
Posted date: 2010-12-16
Communication number: 15332-161725 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rick Dykstra, Member of Parliament | House of Commons
Subject Matter of the communication: Industry, Intellectual Property, Pharmaceutical Policies and Regulations
Communication date: 2010-10-27
Posted date: 2010-11-25
Communication number: 15332-160657 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Megan Leslie, Member of Parliament; NDP Health Critic | House of Commons
Subject Matter of the communication: Health, Pharmaceutical Policies and Regulations
Communication date: 2010-10-18
Posted date: 2010-11-16
Communication number: 15332-158988 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Karen Dodds, Assistant Deputy Minister | Strategic Policy Branch | Health Canada (HC)
- Ron Parker, Senior Assistant Deputy Minister | Industry Sector | Industry Canada
Subject Matter of the communication: Health, Industry, Intellectual Property, Science and Technology, International Trade
Communication date: 2010-05-31
Posted date: 2010-06-16
Communication number: 15332-149777 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leah Canning, Director of Policy | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Pharmaceutical Policies and Regulations
Communication date: 2010-03-30
Posted date: 2010-04-16
Communication number: 15332-145515 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Scott Tessier, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Pharmaceutical Policies and Regulations
Communication date: 2010-03-30
Posted date: 2010-04-16
Communication number: 15332-145514 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gary Lunn, Minister of State (Sport) | Canadian Heritage | Canadian Heritage (PCH)
Subject Matter of the communication: Anti-doping Issue
Communication date: 2009-11-18
Posted date: 2009-12-16
Communication number: 15332-132055 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Scott Tessier, Chief of Staff | Minister's Office | Health Canada (HC)
Subject Matter of the communication: Regulatory Matters
Communication date: 2009-11-04
Posted date: 2009-12-16
Communication number: 15332-132054 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tony Clement, Minister of Industry | Industry Canada
Subject Matter of the communication: Biotechnology
Communication date: 2009-05-19
Posted date: 2009-06-10
Communication number: 15332-108895 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Raylene Johnson, Chief of Staff, Canadian Heritage, Minister of State (Sport) | Canadian Heritage (PCH)
Subject Matter of the communication: Anti-Doping
Communication date: 2009-05-13
Posted date: 2009-06-10
Communication number: 15332-108894 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Laurie Throness, Staffer | House of Commons
Subject Matter of the communication: Industry, Manning Center Dinner - Attended the dinner at Amgen's table
Communication date: 2009-03-12
Posted date: 2009-04-16
Communication number: 15332-100719 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tyler Bjornson, Staffer | House of Commons
Subject Matter of the communication: Industry, Manning Center Dinner - Attended the dinner at Amgen's table
Communication date: 2009-03-12
Posted date: 2009-04-16
Communication number: 15332-100718 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean O'Leary, Staffer | House of Commons
Subject Matter of the communication: Industry, Canadian Club Luncheon - Attended the lunch at Amgen's table
Communication date: 2009-03-10
Posted date: 2009-04-16
Communication number: 15332-100717 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ian Todd, Staffer | House of Commons
Subject Matter of the communication: Industry, Canadian Club Luncheon - Attended the lunch at Amgen's table
Communication date: 2009-03-10
Posted date: 2009-04-16
Communication number: 15332-100716 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Sean O'Leary, Staffer | House of Commons
Subject Matter of the communication: Canadian Club Luncheon - Attended the lunch at Amgen's table
Communication date: 2009-03-10
Posted date: 2009-04-16
Communication number: 15332-100715 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Patrick Muttart, Deputy Chief of Staff | Prime Minister's Office | Prime Minister's Office (PMO)
Subject Matter of the communication: Industry, Biotechnology, Biotech industry needs
Communication date: 2009-03-09
Posted date: 2009-04-16
Communication number: 15332-100714 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Steven Fletcher, Minister of State (Democratic Reform) | Democratic Reform
Subject Matter of the communication: Biotechnology, Biotechnology, update on Biosimilars and CDR
Communication date: 2009-02-09
Posted date: 2009-03-13
Communication number: 15332-97348 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Gary Lunn, Minister of State (Sport) | Canadian Heritage (PCH)
Subject Matter of the communication: World Anti Doping Association (WADA) and Amgen's effort on Anti doping front
Communication date: 2009-02-03
Posted date: 2009-03-13
Communication number: 15332-97347 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Leah Canning, Policy Advisor | Health Canada (HC)
Subject Matter of the communication: Biotechnology
Communication date: 2009-01-20
Posted date: 2009-02-16
Communication number: 15332-91995 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Laurie Throness, Senior Policy Advisor | Health Canada (HC)
- Danielle Shaw, Chief of Staff | Health Canada (HC)
Subject Matter of the communication: Biotechnology
Communication date: 2008-12-16
Posted date: 2009-01-16
Communication number: 15332-90195 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Meena Ballantyne, Assistant Deputy Minister | Health Canada (HC)
Subject Matter of the communication: Biologics, Biotechnology
Communication date: 2008-12-10
Posted date: 2009-01-16
Communication number: 15332-87957 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dan Mader, Director of Policy and Regional Affairs | Ministry of Transport, Infrastructure and Communities
Subject Matter of the communication: biotechnology
Communication date: 2008-11-24
Posted date: 2008-12-16
Communication number: 15332-87956 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Regan Watt, Director of Parliamentary Affairs | Health Canada (HC)
Subject Matter of the communication: Biotechnology
Communication date: 2008-11-24
Posted date: 2008-12-16
Communication number: 15332-87955 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Jim Flaherty, Minister of Finance | Finance Canada (FIN)
Subject Matter of the communication: Biotechnology
Communication date: 2008-11-24
Posted date: 2008-12-16
Communication number: 15332-87954 View associated registration

Ugur Gunaydin, General Manager, Canada (Corporation)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-138 of 138

Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Ophelia John, Senior Policy Advisor | Office of the Minister | Health Canada (HC)
Subject Matter of the communication: Health
Communication date: 2024-03-05
Posted date: 2024-04-15
Communication number: 15332-600597 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Yasir Naqvi, Parliamentary Secretary to the Minister of Health | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597313 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Francesco Sorbara, Member of Parliament for Vaughan—Woodbridge | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597310 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Luc Thériault, Member of Parliament for Montcalm | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597306 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Robert Black, Senator for Ontario | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597303 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Rachel Blaney, Member of Parliament for North Island—Powell River | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597299 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Dan Albas, Member of Parliament for Central Okanagan—Similkameen—Nicola | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597297 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Earl Dreeshen, Member of Parliament for Red Deer—Mountain View | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597293 View associated registration
Amgen Canada Inc.
In-house Corporation

Designated Public Office Holders who participated in the communication:
- Tom Kmiec, Member of Parliament for Calgary Shepard | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-02-29
Posted date: 2024-03-14
Communication number: 15332-597290 View associated registration

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Policy Advisor Ministry of Foreign Affairs, Ministry of Foreign Affairs	November 2005 to January 2006	Not a designated office
Policy Advisor Ministry of International Trade, Ministry of International Trade	January 2004 to November 2005	Not a designated office

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - In-house Corporation

Amgen Canada Inc. / Ugur Gunaydin, General Manager, Canada

Registration Information

Associated Communications

Version 6 of 31 (2009-12-01 to 2011-03-14)

Version 6 of 31 (2009-12-01 to 2011-03-14)

Subject Matters

Subject Matter Details

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Legislative Proposal, Bill or Resolution, Regulation

Policies or Program

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties